Search for: "Teva Pharmaceuticals USA, Inc." Results 101 - 120 of 489
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2018, 11:16 am by Adam Feldman
Teva Pharmaceuticals USA Inc., which asks: “Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
4 Dec 2018, 11:16 am by Andrew Hamm
Teva Pharmaceuticals USA Inc. is also available. [read post]
2 Dec 2018, 9:00 am by Andrew Hamm
Teva Pharmaceuticals USA Inc. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
23 Nov 2018, 8:03 pm by Patent Docs
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2018, 7:05 am by Deborah Heller
This week the Court released the calendar for arguments at the end of November and into December these cases are: Apple, Inc. v. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
17 Sep 2018, 6:48 am by Law Offices of Jeffrey S. Glassman
(Torrent), Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis), and Torrent Pharmaceuticals Limited. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
26 Aug 2018, 4:35 am by Steve Brachmann
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
8 Aug 2018, 1:51 pm by Adam Feldman
The current Supreme Court is friendly toward big business. [read post]